NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$24.07
-0.19 (-0.78%)
▼
5d:
+10.67%
30d:
+15.83%
90d:
+23.18%
WAIT
LOW Confidence
Analysis Updated: Nov 3, 2026 12:00 AM ET
Earnings: Oct 26, 2026
0d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.70
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.89
7.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $24.07, which is considered extended relative to its 30-day fair value range of $19.93 to $22.62. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.7) compared to its historical average (20.2). At these levels, the market is pricing in 4.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NRC is in a uptrend. The price is approaching resistance at $24.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NRC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.00 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRC is in a uptrend. The price is approaching resistance at $24.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NRC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.00 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.93 -
$22.62
Company Quality Score
29/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.4%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($27.00)
- NEUTRAL: Market pricing in 4.0% annual earnings growth - fairly valued
- WARNING: Composite score 29/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.93 -
$22.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.18
Resistance Level
$24.69
Current Trend
Uptrend
Technical data as of
Nov 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.71
Wall Street Target
$27.00
(+12.2%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
16.7%
Profit Margin
4.5%
Valuation Premium vs History
+4.0% premium
PE vs Historical
22.7 vs 20.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.0%
(market-implied from PE analysis)
1-Year Target
$25.03
(+4%)
2-Year Target
$26.03
(+8%)
3-Year Target
$27.08
(+13%)
3-Yr Target (if PE normalizes)
(PE: 23→20)
PE COMPRESSION
$24.09
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.7, Growth: 171.8%)
$81.24
(+238%)
Base:
(SPY PE: 19.9, Growth: 171.8%)
$71.05
(+195%)
Bear:
(PE: 16.9, Growth: 171.8%)
$60.39
(+151%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.40
Bull Case
$29.06
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$24.07
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$18.41
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: November 03, 2026 9:27 PM ET
Data refreshes hourly during market hours. Next update: 10:27 PM
Data refreshes hourly during market hours. Next update: 10:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$301 | 43 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 35 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$82 | 48 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
18 analysts |
$31 | 40 HOLD |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$114 | 43 HOLD |
